Cargando…

The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model

PURPOSE: Boron neutron capture therapy (BNCT) is a selective radiation treatment for tumors that preferentially accumulate drugs carrying the stable boron isotope, (10)B. BNCT has been evaluated clinically as an alternative to conventional radiation therapy for the treatment of brain tumors, and mor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahara, Kiyoshi, Inamoto, Teruo, Minami, Koichiro, Yoshikawa, Yuki, Takai, Tomoaki, Ibuki, Naokazu, Hirano, Hajime, Nomi, Hayahito, Kawabata, Shinji, Kiyama, Satoshi, Miyatake, Shin-Ichi, Kuroiwa, Toshihiko, Suzuki, Minoru, Kirihata, Mitsunori, Azuma, Haruhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556531/ https://www.ncbi.nlm.nih.gov/pubmed/26325195 http://dx.doi.org/10.1371/journal.pone.0136981

Ejemplares similares

E74-like factor inhibition induces reacquisition of hormone sensitiveness decreasing period circadian protein homolog 1 expression in prostate cancer cells()
por: Koyama, Kohei, et al.
Publicado: (2015)

Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case report
por: Tsujino, Takuya, et al.
Publicado: (2017)

A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder
por: Inamoto, Teruo, et al.
Publicado: (2018)

The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma
por: Tsujino, Takuya, et al.
Publicado: (2017)

Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~
por: Tsutsumi, Takeshi, et al.
Publicado: (2021)

Single session of high-intensity focused ultrasound for localized prostate cancer: treatment outcomes and potential effect as a primary therapy
por: Komura, Kazumasa, et al.
Publicado: (2013)

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft
por: Inamoto, Teruo, et al.
Publicado: (2015)

Effectiveness of Factor XIII Infusion in Treatment of Refractory Ureteral Leakage after Kidney Transplantation
por: Maenosono, Ryoichi, et al.
Publicado: (2020)

Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort
por: Komura, Kazumasa, et al.
Publicado: (2019)

The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma
por: Inamoto, Teruo, et al.
Publicado: (2017)

MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells
por: Minami, Koichiro, et al.
Publicado: (2017)

Early Prostate-Specific Antigen (PSA) Change at Four Weeks of the First-Line Treatment Using Abiraterone and Enzalutamide Could Predict Early/Primary Resistance in Metastatic Castration-Resistant Prostate Cancer
por: Uchimoto, Taizo, et al.
Publicado: (2021)

Induction of erythropoietin increases the cell proliferation rate in a hypoxia-inducible factor-1-dependent and -independent manner in renal cell carcinoma cell lines
por: FUJISUE, YUTAKA, et al.
Publicado: (2013)

Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
por: Futamura, Gen, et al.
Publicado: (2017)

A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells
por: Takai, Tomoaki, et al.
Publicado: (2017)

Unplanned hemodialysis initiation and low geriatric nutritional risk index scores are associated with end-stage renal disease outcomes
por: Maenosono, Ryoichi, et al.
Publicado: (2022)

Post-operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non-urothelial recurrence and other clinical indicators
por: TAKAHARA, KIYOSHI, et al.
Publicado: (2013)

Immunotherapy of Genitourinary Malignancies
por: Inamoto, Teruo, et al.
Publicado: (2012)

Editorial Comment to Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade
por: Inamoto, Teruo, et al.
Publicado: (2019)

Editorial Comment to Prostate carcinoma with neuroendocrine differentiation successfully treated by early detection with imaging examination
por: Inamoto, Teruo, et al.
Publicado: (2020)

Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment
por: Yoshikawa, Yuki, et al.
Publicado: (2019)

Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study
por: Inamoto, Teruo, et al.
Publicado: (2018)

Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)

Risk Classification for Overall Survival by the Neutrophil–Lymphocyte Ratio and the Number of Metastatic Sites in Patients Treated with Pembrolizumab—A Multicenter Collaborative Study in Japan
por: Uchimoto, Taizo, et al.
Publicado: (2021)

Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map
por: Hiramatsu, Ryo, et al.
Publicado: (2013)

Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014)

Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents
por: Komura, Kazumasa, et al.
Publicado: (2021)

Development and Elucidation of a Novel Fluorescent Boron-Sensor for the Analysis of Boronic Acid-Containing Compounds
por: Hattori, Yoshihide, et al.
Publicado: (2017)

Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
por: Takeuchi, Koji, et al.
Publicado: (2020)

MicroRNA‐143/Musashi‐2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer
por: Tsujino, Takuya, et al.
Publicado: (2019)

Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy may be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate Cancer
por: Inamoto, Teruo, et al.
Publicado: (2011)

CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer
por: Tsujino, Takuya, et al.
Publicado: (2021)

A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
por: Futamura, Gen, et al.
Publicado: (2014)

A case of congenital single testis with testicular cancer patient and azoospermia who was able to collect spermatozoa with ipsilateral Onco‐TESE
por: Hayashi, Kazumasa, et al.
Publicado: (2020)

Synthesis and cytotoxicity of the boron carrier pentagamaboronon-0-ol for boron neutron capture therapy against breast cancer
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022)

The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
por: Fukuo, Yusuke, et al.
Publicado: (2020)

Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
por: Susidarti, Ratna Asmah, et al.
Publicado: (2019)

Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette–Guérin prophylaxis in nonmuscle invasive bladder cancer: Results of a randomized prospective comparison
por: Inamoto, Teruo, et al.
Publicado: (2013)

Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo
por: Takai, Tomoaki, et al.
Publicado: (2019)

Evaluation of the Potential of p‐Boronophenylalaninol as a Boron Carrier in Boron Neutron Capture Therapy, Referring to the Effect on Intratumor Quiescent Cells
por: Masunaga, Shin‐ichiro, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_ejfscga12rdm5ceitroup6nbmu